Investment Technology Group Rating Increased to Outperform at Zacks (ITG)

Share on StockTwits

Zacks upgraded shares of Investment Technology Group (NYSE: ITG) from a neutral rating to an outperform rating in a report issued on Monday, StockRatingsNetwork reports. They currently have $14.90 target price on the stock.

Investment Technology Group (NYSE: ITG) traded down 0.28% on Monday, hitting $14.00. Investment Technology Group has a 1-year low of $7.43 and a 1-year high of $14.50. The stock’s 50-day moving average is currently $12.59. The company’s market cap is $521.0 million.

Other equities research analysts have also recently issued reports about the stock. Analysts at Keefe, Bruyette & Woods raised their price target on shares of Investment Technology Group from $13.00 to $14.00 in a research note to investors on Friday, May 3rd. Analysts at Sandler O’Neill cut their price target on shares of Investment Technology Group from $12.00 to $11.50 in a research note to investors on Tuesday, April 9th.

One research analyst has rated the stock with a hold rating and two have given a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $12.85.

Investment Technology Group, Inc. (NYSE: ITG) is an independent agency brokerage and financial technology firm, which partners with asset managers to deliver institutional global liquidity and help improve performance throughout the investment process.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

Pentagon Teaming Up with Boeing and Apple for Wearable Tech
Pentagon Teaming Up with Boeing and Apple for Wearable Tech
One-Hour Delivery by Amazon Arrives in Seattle
One-Hour Delivery by Amazon Arrives in Seattle
Dangerous Bacteria in Ground Beef Shows Study
Dangerous Bacteria in Ground Beef Shows Study
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Sears Reports Profit for the Quarter But Sales Drop
Sears Reports Profit for the Quarter But Sales Drop
Lenovo Sets Up Manufacturing Facility in India
Lenovo Sets Up Manufacturing Facility in India


Advertisement
Advertisement
© 2006-2015 Ticker Report. Google+.